Your browser doesn't support javascript.
loading
Relation of Length of Survival After Orthotopic Heart Transplantation to Age of the Donor.
Shudo, Yasuhiro; Guenther, Sabina Pw; Lingala, Bharathi; He, Hao; Hiesinger, William; MacArthur, John W; Currie, Maria E; Lee, Anson M; Boyd, Jack H; Woo, Y Joseph.
Afiliación
  • Shudo Y; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Guenther SP; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Lingala B; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • He H; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Hiesinger W; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • MacArthur JW; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Currie ME; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Lee AM; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Boyd JH; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Woo YJ; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California. Electronic address: joswoo@stanford.edu.
Am J Cardiol ; 131: 54-59, 2020 09 15.
Article en En | MEDLINE | ID: mdl-32736794
We aim to evaluate the impact of donor age on the outcomes in orthotropic heart transplantation recipients. The United Network for Organ Sharing database was queried for adult patients (age; ≥60) underwent first-time orthotropic heart transplantation between 1987 and 2019 (n = 18,447). We stratified the cohort by donor age; 1,702 patients (9.2%) received a heart from a donor age of <17 years; 11,307 patients (61.3%) from a donor age of 17 ≥, < 40; 3,525 patients (19.1%) from a donor age of 40 ≥, < 50); and 1,913 patients (10.4%) from a donor age of ≥50. There was a significant difference in the survival likelihood (p < 0.0001) based on donor's age-based categorized cohort, however, the median survival was 10.5 years in the cohort in whom the donor was <17, 10.3 years in whom the donor was 17 ≥, < 40, 9.4 years in whom the donor was 40 ≥, < 50, and 9.0 years in whom the donor was ≥ 50. Additionally, there was no significant difference in the episode of acute rejection (p = 0.19) nor primary graft failure (p = 0.24). In conclusion, this study demonstrated that patients receiving hearts from the donor age of ≥50 years old showed slight inferior survival likelihood, but appeared to be equivalent median survival.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Corazón / Supervivencia de Injerto Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Donantes de Tejidos / Trasplante de Corazón / Supervivencia de Injerto Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos